- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lupin Digital Health collaborate with Medicover Hospitals for post-discharge cardiac care
Mumbai: Lupin Digital Health, a wholly owned subsidiary of global pharma major Lupin Limited has announced a transformative collaboration with Medicover Hospitals to provide state-of-the-art post-operative rehabilitation and care for Medicover’s cardiac patients.
"This partnership aims to reshape cardiac care in India, offering at-home rehabilitation, powered by digital therapeutics. It strives to enable seamless care to patients post a cardiac event, providing support through easy monitoring and adherence to treatments," the company stated.
Medicover Hospitals, has chosen Lupin Digital Health’s Digital Therapeutics (DTx) platform, Lyfe to accelerate its cardiac care services.
The platform was licensed as a Class C Medical Device by the regulator CDSCO, Government of India.
Rajeev Sibal, President – India Region Formulations, Lupin said, "Our partnership with Medicover Hospitals signifies a crucial step forward in paving the way for advanced digital health solutions to cardiac patients in India. This will ensure personalized care for cardiac patients, significantly improving their recovery and adherence to treatment plans.”
Sidharth Srinivasan, CEO of Lupin Digital Health added, “The post-discharge phase of cardiac rehab has historically been a challenge, with many patients experiencing lapses in care. Through this partnership, Medicover has taken the forward-looking step of ensuring that patients across India receive the continuous support they need. This is critical in addressing the issue of non-adherence by patients.”
Dr. Sharath Reddy, Executive Director and Senior Interventional Cardiologist, Medicover Group of Hospitals, emphasized the significance of this initiative, “Medicover is one of the fastest growing multispecialty hospital chains in India, known for best-in-class cardiac using cutting-edge imaging and cardiac surgery technologies to ensure that patients receive the highest quality care available. Through our partnership with LYFE by Lupin Digital Health, we wish to extend comprehensive in-home cardiovascular care. Together, we will address critical gaps in post-discharge care.”
Medicover will offer these comprehensive cardiac care programmes, powered by Lupin Digital Health, across their entire network of multispecialty hospitals.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751